In The News Posted June 5, 2019 Share Posted June 5, 2019 KANAGAWA, Japan and BOTHELL, Wash., June 5, 2019 /PRNewswire/ -- PeptiDream Inc., a public Kanagawa-based biopharmaceutical company ("PeptiDream")(TOKYO:4587) announced today a strategic partnership with Seattle-based PharmaIN Corporation ("PharmaIN") for the purpose of investigating the... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.